Literature DB >> 11238928

Coordinated regulation of Rap1 and thyroid differentiation by cyclic AMP and protein kinase A.

O M Tsygankova1, A Saavedra, J F Rebhun, L A Quilliam, J L Meinkoth.   

Abstract

Originally identified as an antagonist of Ras action, Rap1 exhibits many Ras-independent effects, including a role in signaling pathways initiated by cyclic AMP (cAMP). Since cAMP is a critical mediator of the effects of thyrotropin (TSH) on cell proliferation and differentiation, we examined the regulation of Rap1 by TSH in a continuous line of rat thyroid-like cells. Both cAMP and protein kinase A (PKA) contribute to the regulation of Rap1 activity and signaling by TSH. TSH activates Rap1 through a cAMP-mediated and PKA-independent mechanism. TSH phosphorylates Rap1 in a PKA-dependent manner. Interference with PKA activity blocked phosphorylation but not the activation of Rap1. Rather, PKA inhibitors prolonged Rap1 activation, as did expression of a Rap1A mutant lacking a PKA phosphorylation site. These results indicate that PKA elicits negative feedback regulation on cAMP-stimulated Rap1 activity in some cells. The dual regulation of Rap1 by cAMP and PKA extends to downstream effectors. The ability of TSH to stimulate Akt phosphorylation was markedly enhanced by the expression of activated Rap1A and was repressed in cells expressing a putative dominant-negative Rap1A mutant. Although the expression of activated Rap1A was sufficient to stimulate wortmannin-sensitive Akt phosphorylation, TSH further increased Akt phosphorylation in a phosphatidylinositol 3-kinase- and PKA-dependent manner. The ability of TSH to phosphorylate Akt was impaired in cells expressing a Rap1A mutant that could be activated but not phosphorylated. These findings indicate that dual signals, Rap1 activation and phosphorylation, contribute to TSH-stimulated Akt phosphorylation. Rap1 plays an essential role in cAMP-regulated differentiation. TSH effects on thyroid-specific gene expression, but not its effects on proliferation, were markedly enhanced in cells expressing activated Rap1A and repressed in cells expressing a dominant-negative Rap1A mutant. These findings reveal complex regulation of Rap1 by cAMP including PKA-independent activation and PKA-dependent negative feedback regulation. Both signals appear to be required for TSH signaling to Akt.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11238928      PMCID: PMC86776          DOI: 10.1128/MCB.21.6.1921-1929.2001

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  52 in total

Review 1.  Physiological and pathological regulation of thyroid cell proliferation and differentiation by thyrotropin and other factors.

Authors:  J E Dumont; F Lamy; P Roger; C Maenhaut
Journal:  Physiol Rev       Date:  1992-07       Impact factor: 37.312

2.  Mitogenic and oncogenic properties of the small G protein Rap1b.

Authors:  D L Altschuler; F Ribeiro-Neto
Journal:  Proc Natl Acad Sci U S A       Date:  1998-06-23       Impact factor: 11.205

3.  Deficient post-translational processing of Rap 1A in variant HL-60 cells.

Authors:  J S Scheele; R B Pilz; F C von Lintig; G R Boss
Journal:  Oncogene       Date:  1998-10-29       Impact factor: 9.867

4.  The cyclic adenosine monophosphate-dependent protein kinase (PKA) is required for the sustained activation of mitogen-activated kinases and gene expression by nerve growth factor.

Authors:  H Yao; R D York; A Misra-Press; D W Carr; P J Stork
Journal:  J Biol Chem       Date:  1998-04-03       Impact factor: 5.157

5.  AP1 proteins mediate the cAMP response of the dopamine beta-hydroxylase gene.

Authors:  D J Swanson; E Zellmer; E J Lewis
Journal:  J Biol Chem       Date:  1998-09-11       Impact factor: 5.157

6.  Inhibition of Rap1A binding to cytochrome b558 of NADPH oxidase by phosphorylation of Rap1A.

Authors:  G M Bokoch; L A Quilliam; B P Bohl; A J Jesaitis; M T Quinn
Journal:  Science       Date:  1991-12-20       Impact factor: 47.728

7.  Epac is a Rap1 guanine-nucleotide-exchange factor directly activated by cyclic AMP.

Authors:  J de Rooij; F J Zwartkruis; M H Verheijen; R H Cool; S M Nijman; A Wittinghofer; J L Bos
Journal:  Nature       Date:  1998-12-03       Impact factor: 49.962

8.  Rap1A is a substrate for cyclic AMP-dependent protein kinase in human neutrophils.

Authors:  L A Quilliam; H Mueller; B P Bohl; V Prossnitz; L A Sklar; C J Der; G M Bokoch
Journal:  J Immunol       Date:  1991-09-01       Impact factor: 5.422

9.  Enhancement of the actions of smg p21 GDP/GTP exchange protein by the protein kinase A-catalyzed phosphorylation of smg p21.

Authors:  Y Hata; K Kaibuchi; S Kawamura; M Hiroyoshi; H Shirataki; Y Takai
Journal:  J Biol Chem       Date:  1991-04-05       Impact factor: 5.157

Review 10.  Molecular events involved in differentiation of thyroid follicular cells.

Authors:  C Missero; G Cobellis; M De Felice; R Di Lauro
Journal:  Mol Cell Endocrinol       Date:  1998-05-25       Impact factor: 4.102

View more
  34 in total

1.  HMG-CoA reductase inhibitors inhibit rat propylthiouracil-induced goiter by modulating the ras-MAPK pathway.

Authors:  Chiara Laezza; Gherardo Mazziotti; Laura Fiorentino; Patrizia Gazzerro; Giuseppe Portella; Diego Gerbasio; Carlo Carella; Giuseppe Matarese; Maurizio Bifulco
Journal:  J Mol Med (Berl)       Date:  2006-09-01       Impact factor: 4.599

2.  Rap1 promotes multiple pancreatic islet cell functions and signals through mammalian target of rapamycin complex 1 to enhance proliferation.

Authors:  Patrick Kelly; Candice L Bailey; Patrick T Fueger; Christopher B Newgard; Patrick J Casey; Michelle E Kimple
Journal:  J Biol Chem       Date:  2010-03-25       Impact factor: 5.157

Review 3.  Small G proteins as key regulators of pancreatic digestive enzyme secretion.

Authors:  John A Williams; Xuequn Chen; Maria E Sabbatini
Journal:  Am J Physiol Endocrinol Metab       Date:  2008-12-16       Impact factor: 4.310

4.  Hindbrain GLP-1 receptor-mediated suppression of food intake requires a PI3K-dependent decrease in phosphorylation of membrane-bound Akt.

Authors:  Laura E Rupprecht; Elizabeth G Mietlicki-Baase; Derek J Zimmer; Lauren E McGrath; Diana R Olivos; Matthew R Hayes
Journal:  Am J Physiol Endocrinol Metab       Date:  2013-07-30       Impact factor: 4.310

5.  Deletion of Rap1b, but not Rap1a or Epac1, Reduces Protein Kinase A-Mediated Thyroid Cancer.

Authors:  Danielle J Huk; Amruta Ashtekar; Alexa Magner; Krista La Perle; Lawrence S Kirschner
Journal:  Thyroid       Date:  2018-08-02       Impact factor: 6.568

6.  A novel Epac-Rap-PP2A signaling module controls cAMP-dependent Akt regulation.

Authors:  Kyoungja Hong; Liguang Lou; Sandhya Gupta; Fernando Ribeiro-Neto; Daniel L Altschuler
Journal:  J Biol Chem       Date:  2008-06-12       Impact factor: 5.157

7.  Switch in signaling control of mTORC1 activity after oncoprotein expression in thyroid cancer cell lines.

Authors:  Roberta Malaguarnera; Kuen-Yuan Chen; Tae-Yong Kim; Jose M Dominguez; Francesca Voza; Bin Ouyang; Sushil K Vundavalli; Jeffrey A Knauf; James A Fagin
Journal:  J Clin Endocrinol Metab       Date:  2014-07-16       Impact factor: 5.958

8.  Histone deacetylase inhibitors upregulate Rap1GAP and inhibit Rap activity in thyroid tumor cells.

Authors:  Xiaoyun Dong; Christopher Korch; Judy L Meinkoth
Journal:  Endocr Relat Cancer       Date:  2011-04-02       Impact factor: 5.678

9.  Rap1GAP impairs cell-matrix adhesion in the absence of effects on cell-cell adhesion.

Authors:  Lisa A Vuchak; Oxana M Tsygankova; Judy L Meinkoth
Journal:  Cell Adh Migr       Date:  2011-07-01       Impact factor: 3.405

10.  A Rap/phosphatidylinositol 3-kinase pathway controls pseudopod formation [corrected].

Authors:  Arjan Kortholt; Parvin Bolourani; Holger Rehmann; Ineke Keizer-Gunnink; Gerald Weeks; Alfred Wittinghofer; Peter J M Van Haastert
Journal:  Mol Biol Cell       Date:  2010-01-20       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.